Indian Vaccine Makers Face Loss Of WHO Sales By DGIC Delay
This article was originally published in PharmAsia News
Executive Summary
India's vaccine makers face loss of permission to sell their drugs to the United Nations because their National Regulatory Authority has not implemented Good Manufacturing Practices. The NRA is headed by the Drug Controller General of India. The WHO already had closed three public-sector Indian units because of noncompliance in January, but many more companies face the inability to have their vaccines pre-qualified for U.N. agencies and foundations that also require the designation. The WHO relies on Indian drug makers for as much as 80 percent of the vaccines it buys annually. (Click here for more